Galderma Korea Appoints Kim Ji-hee as Executive Director of Prescription Business Division
[Asia Economy Reporter Lee Gwan-joo] Galderma Korea announced on the 19th that it has newly appointed Executive Director Kim Ji-hee as the head of the Prescription Business Division.
Executive Director Kim holds a bachelor's degree in Biology from Konkuk University and a master's degree in Business Administration (MBA) from Korea University. She has accumulated practical experience and marketing capabilities over 17 years across various specialized therapeutic fields in the global healthcare industry, including at MSD Korea, Mundipharma Korea, and AstraZeneca Korea.
As the new head of Galderma Korea's Prescription Business Division, Executive Director Kim is expected to strengthen the portfolio of various dermatological treatments such as Aklief and Soolantra, and lead business growth and expansion.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Executive Director Kim said, "I am pleased to join Galderma Korea, the world's largest dermatology specialist company with unparalleled leadership and expertise in the field of dermatological treatments," adding, "I will focus on providing optimal treatment options to patients with skin diseases by enhancing the expertise of the Prescription Business Division, while doing my best to create business opportunities that can promote the division's growth."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
